SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-11-003381
Filing Date
2011-01-21
Accepted
2011-01-21 16:07:10
Documents
3
Period of Report
2011-01-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 v208663_8k.htm 8-K 194245
2 v208663_ex1-1.htm EX-1.1 253843
3 v208663_ex5-1.htm EX-5.1 13181
  Complete submission text file 0001144204-11-003381.txt   463036
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

IRS No.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24006 | Film No.: 11541507
SIC: 2834 Pharmaceutical Preparations